{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-025006","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.399073+00:00","generated_at":"2026-05-21T16:33:58.909815+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CAFC affirms validity of AbCellera's microfluidic cell culture patent against Bruker challenge","bullets":["Federal Circuit affirms PTAB decision upholding all claims of U.S. Patent No. 10,087,408.","Patent covers microfluidic devices for culturing and selective recovery of cells.","Bruker Cellular (formerly Berkeley Lights) challenged validity on anticipation/obviousness grounds; both PTAB and CAFC rejected arguments.","Ongoing multi-patent infringement suit between AbCellera and Bruker pending in N.D. California.","AbCellera CEO expects to prove infringement case against Bruker in district court."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-025006","json":"https://secwatch.observer/filing/0001628280-25-025006.json","markdown":"https://secwatch.observer/filing/0001628280-25-025006.md","text":"https://secwatch.observer/filing/0001628280-25-025006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025025006/0001628280-25-025006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025025006/abcl-20250512.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T16:33:58.909815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}